Nordic Diltiazem Study "NORDIL"

Completed

Phase N/A Results

Summary of Purpose

To compare the efficacy of a calcium-channel blocker (diltiazem) with those of beta-blockers and diuretics in preventing major cardiovascular events in hypertensive patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 June 2002.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Pharamacia-Upjohn, Inc., Kalamazoo, MI

Trial Design

Not available

Contacts

Not available